InvestorsHub Logo

jamtomorrow2

04/06/17 1:49 PM

#5230 RE: tjguy #5229

A contested takeover approach from both Roche and JNJ may help a tad. Other than that it is going to be a long painful waiting game with no short term catalysts on the horizon this year (other than Mab) - just more huge losses.